<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-99541</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>Masjuan, Jaime</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Rev Neurol;54(5): 257-259, mar. 2012.</dc:source>
<dc:identifier>ibc-99541</dc:identifier>
<dc:title xml:lang="es">Controversia. Dabigatrán en el tratamiento preventivo del ictus embólico: a favor de su utilización como fármaco de primera línea</dc:title>
<dc:subject>^d1287^s22012</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d15213^s22006</dc:subject>
<dc:subject>^d34257^s22054</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d34247^s22054</dc:subject>
<dc:subject>^d932^s22079</dc:subject>
<dc:type>article</dc:type>
<dc:date>201203</dc:date>
</metadata>
</record>
</ibecs-document>
